Conference - San Francisco, CA, United States
We invite you to attend the 4th Cancer Epigenetics Conference, which will take place on November 16-17, 2015 in San Francisco, CA. Lately the field of epigenetics has been rapidly changing and progressing. Advances that were made possible because of the Human Genome Project have opened up new possibilities about how epigenetics can be used to stop cancer. Scientists have recently discovered that there are potentially two sets of enzymes that are responsible for regulating the chemical structure of chromatin, which consists of the methyl and acetyl marks in the chromatin structure. Theoretically, by changing and controlling the chromatin structure, scientists can attempt to gain epigenetic control of DNA in order to potentially stop aberrant gene expression. Interest in applying and translating epigenetic science to cancer therapy is growing at an exponential pace.We invite you to join us as colleagues from industry and academia gather to discuss the latest research for therapeutics, drug discovery developments, biomarkers, and epigenetic mechanisms in cancer.
Organization: GTCbio
For more information, please visit: http://www.gtcbio.com/conferences/cancer-epigenetics-overview?utm_source=4cancerepi&utm_medium=eventlisting&utm_campaign=overview
November 16-17, 2015 (08:00 am-05:00 pm)
San Francisco, CA 94115, United States
Contact: Kristen Starkey (infogtcbio@gtcbio.com)
Phone: 6262566405
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
